首页 | 本学科首页   官方微博 | 高级检索  
检索        

舒肝解郁胶囊联合安非他酮治疗老年抑郁症的疗效观察
引用本文:段海水,吕贝,赵玉林,尹祖斌.舒肝解郁胶囊联合安非他酮治疗老年抑郁症的疗效观察[J].现代药物与临床,2017,32(2):289-292.
作者姓名:段海水  吕贝  赵玉林  尹祖斌
作者单位:1. 重庆三峡中心医院平湖分院心身康复科,重庆,404000;2. 重庆三峡中心医院平湖分院女性心理卫生科,重庆,404000;3. 哈尔滨市第一医院精神心理科,黑龙江哈尔滨,150001
摘    要:目的探究舒肝解郁胶囊联合安非他酮片治疗老年抑郁症的临床疗效。方法选取2013年6月—2016年6月于重庆三峡中心医院平湖分院进行就诊的老年抑郁症患者120例,按随机抽样法分为对照组和治疗组,每组各60例。对照组口服盐酸安非他酮片,起始量75 mg/d,2周内根据病情增加剂量,最大剂量为300 mg/d。治疗组在对照组基础上口服舒肝解郁胶囊,0.72 g/次,2次/d。两组患者均治疗8周。观察两组的临床疗效,比较两组的汉密尔顿抑郁量表(HAMD)评分和汉密尔顿焦虑量表(HAMA)评分的情况。结果治疗后,对照组和治疗组的总有效率分别为71.7%、85.0%,两组比较差异有统计学意义(P0.05)。治疗4、6、8周后,两组HAMD评分和HAMA评分均显著下降,同组治疗前后比较差异有统计学意义(P0.05);且治疗8周后,治疗组观察指标的下降程度明显优于对照组,两组比较差异具有统计学意义(P0.05)。结论舒肝解郁胶囊联合安非他酮片治疗老年抑郁症具有较好的临床疗效,可改善临床症状,安全性较好,具有一定的临床推广应用价值。

关 键 词:舒肝解郁胶囊  盐酸安非他酮片  老年抑郁症  HAMD评分  HAMA评分
收稿时间:2016/11/14 0:00:00

Clinical observation of Shugan Jieyu Capsules combined with bupropion in treatment of senile depression
DUAN Hai-shui,L&#; Bei,ZHAO Yu-lin and YIN Zu-bin.Clinical observation of Shugan Jieyu Capsules combined with bupropion in treatment of senile depression[J].Drugs & Clinic,2017,32(2):289-292.
Authors:DUAN Hai-shui  L&#; Bei  ZHAO Yu-lin and YIN Zu-bin
Institution:Department of Psychosomatic Rehabilitation, Pinghu Branch of Chongqing Three Gorges Central Hospital, Chongqing 404000, China;Department of Female Mental Health, Pinghu Branch of Chongqing Three Gorges Central Hospital, Chongqing 404000, China;Department of Psychiatry, Harbin the First Hospital, Harbin 150010, China;Department of Psychosomatic Rehabilitation, Pinghu Branch of Chongqing Three Gorges Central Hospital, Chongqing 404000, China
Abstract:Objective To explore the clinical effect of Shugan Jieyu Capsules combined with Bupropion Hydrochloride Tablets in treatment of senile depression. Methods Patients (120 cases) with senile depression in Pinghu Branch of Chongqing Three Gorges Central Hospital from June 2013 to June 2016 were randomly divided into control and treatment groups, and each group had 60 cases. Patients in the control group were po administered with Bupropion Hydrochloride Tablets, starting dosage was 75 mg/d, increased the dose according to the condition within 2 weeks, and maximum dosage was 300 mg/d. Patients in the treatment group were po administered with Shugan Jieyu Capsules on the basis of the control group, 0.72 g/time, twice daily. Patients in two groups were treated for 8 weeks. After treatment, the clinical efficacies were evaluated, and HAMD scores and HAMA scores in two groups were compared. Results After treatment, the clinical efficacies in the control and treatment groups were 71.7% and 85.0%, respectively, and there was difference between two groups (P<0.05). After treatment for 4, 6, 8 weeks, HAMD scores and HAMA scores in two groups were significantly decreased, and the difference was statistically significant in the same group (P<0.05). And after treatment for 8 weeks, the observational indexes in the treatment group were significantly lower than those in the control group, with significant difference between two groups (P<0.05). Conclusion Shugan Jieyu Capsules combined with Bupropion Hydrochloride Tablets has effect in treatment of senile depression, can improve clinical symptoms with good safety, which has a certain clinical application value.
Keywords:Shugan Jieyu Capsules  Bupropion Hydrochloride Tablets  senile depression  HAMD score  HAMA score
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《现代药物与临床》浏览原始摘要信息
点击此处可从《现代药物与临床》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号